Related Experiment Video
Updated: Aug 30, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Epidemiology of human parvovirus B19 in children with sickle cell disease
Kim Smith-Whitley1, Huaqing Zhao, Richard L Hodinka
1Division of Hematology, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, USA. whitleyk@email.chop.edu
Insights
Human parvovirus (HPV) B19 frequently infects children with sickle cell disease (SCD), causing aplastic crises. This study highlights the high incidence and severe complications of HPV B19 in SCD patients, emphasizing the need for prevention.
Area of Science:
- Pediatric Hematology
- Infectious Diseases Epidemiology
- Viral Pathogenesis
Background:
- Human parvovirus (HPV) B19 is a known cause of significant illness in children with sickle cell disease (SCD).
- Limited epidemiological data exists on HPV B19 infection and its complications within the SCD population.
Purpose of the Study:
- To determine the prevalence and incidence of HPV B19 infection in children with SCD.
- To characterize the clinical complications associated with acute HPV B19 infection in this cohort.
Main Methods:
- Prospective cohort study of 633 children with SCD from November 1996 to December 2001.
- Annual testing for HPV B19 infection in susceptible individuals.
- Documentation of clinical events during acute HPV B19 infections.
Main Results:
- 30% of SCD patients had prior HPV B19 exposure (IgG positive).
- Incidence rate of HPV B19 infection was 11.3 per 100 patient-years.
- Common complications included fever (89.7%), pain (61.8%), aplastic crisis (68 episodes), acute splenic sequestration (19.1%), and acute chest syndrome (11.8%).
- Pain, fever, and splenic sequestration were more frequent during HPV B19 infections compared to non-infected patients.
Conclusions:
- HPV B19 infection is highly incident in children with SCD.
- Acute HPV B19 infection leads to frequent and severe complications, including aplastic crisis, pain, and splenic sequestration.
- Development of HPV B19 prevention strategies is warranted for this vulnerable population.
Abstract:
Human parvovirus (HPV) B19 causes significant morbidity and mortality in children with sickle cell disease (SCD), but little data are published about the epidemiology of HPV B19 infection and its associated complications in this patient population. In this study, prevalence and incidence rates of HPV B19 were determined in 633 patients with SCD followed at The Children's Hospital of Philadelphia between November 1996 and December 2001. Thirty percent (30%) were HPV B19 immunoglobulin G (IgG) positive at first testing, and the 70% without evidence of past HPV B19 infection were tested annually. One hundred ten patients developed evidence of HPV B19 infection for an incidence rate of 11.3 per 100 patient years. Sixty-eight episodes of HPV B19-induced transient red cell aplasia occurred with the following clinical events: fever (89.7%), pain (61.8%), acute splenic sequestration (19.1%), and acute chest syndrome (11.8%). Pain, fever, and acute splenic sequestration were more frequent events with acute HPV B19 infections compared with acute events in uninfected patients. The results of this epidemiologic study, the largest and most comprehensive to date, justify the development of HPV B19 prevention strategies to diminish the frequent and often severe complications associated with HPV B19 infections in patients with SCD.
Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Poliomyelitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Infectious Diseases and Their Occurrence
Malaria